you Thanks, thank and Doug. Good joining afternoon us for today.
with of believe in the currently portfolio to solutions, that's thrilled spatial and spatial compelling offers are biology ongoing NanoString biology the extend researchers the innovations will most we We market. lead. that our continue building momentum
we are As spatial XXXX, priorities poised as and we market. demand before revenue that mix XXXX. and backlog cell fourth growth. biology XXXX imagers XXXX and fiscal single was of believe for both begin I'll we our of enjoyed strong substantial outlining the expanded recapping arrival by transition growing for within both year begin highlights our and from quarter some a demand the for year in shift a
Spatial our of XX% biology best-in-class this to orders to who Digital our Imagers, biology. XX% about researchers spatial Spatial GeoMx broadened base Profiler. Molecular CosMx the year-on-year XXX approximately allowed oncology single capitalize who our cell CosMx core discovery from by With and NanoString. in total beyond are reaching past, we orders customers has to the our us able our researchers, to we've who've on grew process, across new This customer we served trend were the embraced systems instrument and In CosMx generate
strong. particularly the Our finish to year was
captured shipments. a $XX XXX CosMx build and QX, we the first During we for ship had began instruments CosMx generated year-end, spatial backlog valued orders delivering At orders the million. around and for than commercial at XXX more SIP revenue – approximately instruments
Nature featured a gracing of cell XXXX surpassed protein papers single cover. scientific as tremendous Biotechnology spatial and image issue in December platforms. high momentum technologies CosMx with biology enabled by our we saw of We from X,XXX approximately XXX also was RNA including our peer-reviewed using that CosMx the journal's resolution
by Magazine research innovations XX top to in highlighting the understanding. advance that annual and of survey their revolutionize scientific one as The products poised our recognized Scientist also was are CosMx
more mainstream highlighted article to platforms Alzheimer's GeoMx Center Wake in Forest both an research high also from the perform brain January which which biology spatial media, University mapping Our issue as reached Medical Geographic, aging, of tissue. of and using on National CosMx revolution contained
us XXXX, early in we convinced leading our began markets. As spatial innovation we're advantage, the of engine, position and our product our the that scalability mover biology technologies a put in
to outline provide of an the I'd strategic ahead. like for our objectives Now year
is infancy. only XXXX research its the method the billion across market. X% market biology for biology labs, objective have is valued that has spatial first been X,XXX of addressable alone still the the year in field Spatial of which was date. penetrate penetrated ago, We two and to estimate nature's biology at to Our just in rapidly years spatial $X
focus Biology representing in Genome the market is Advances roadmap XXXX kicked Congress, total the We year or prominently off on our at XX% portfolio presentations biology share this AGBT. Our featured as important but and in of develops, instrument on and updates orders Spatial AGBT winning about spatial our biology this successful. customers product capturing posters. making Technology providing at by and
the nearest which NanoString meeting, in We the discovery capitalized the know our NanoString. most basic showing. studies to competitor. the are could almost spatial for row provider, pleased who in with any of sponsor I year had AGBT researchers, more and perfect be brand be of abstracts to provides second getting doubled spatial not opportunity biology this build our to venue gold with on the of number still technology year's a For a our
spatial attendees NanoString published company. exciting most space mentioned conclusion a with the of that consulting most firm Following the of the the DeciBio rated biology at meeting, survey
meeting, three we the key achieved During objectives.
appreciate was open wait and scalable extremely Spatial for interest ordered infrastructure. to cost a system to also provided focus building get source of positive. AtoMx of customers our biology hands the in AtoMx AtoMx. headaches of compute provides Those and already avoid Platform. high, AtoMx is them CosMx storage Think scalable own we platform cannot demos provides total conducted onsite maintaining who cloud the AtoMx plus and cloud-based an capabilities science Feedback that Researchers allows making for ecosystem. one. extremely analysis the flexible, researchers. meeting. of of publicly CosMx the data upfront have a this have the the we Informatics the to their and spatial highly biology of decision First, is from on fraction solution spatial on their the and Customer move during power demonstrated storage and compute AtoMx NanoString's a dozens secure iCloud AtoMx informatics the easy to that by storage
our assay class roadmap, will a from Plex amount plex. describe samples. can is number continue to We the determines to the directly of generated unveil believe or Second, it imager the the standard that platform to which the is set as unique AGBT proteins CosMx we plex genes the used used spatial critical for analyze. information most differentiator precious term of in
Our our stands higher we manufacturers. assay, CosMx XXXX cheaper as belief plex that plex assay. offered head Plex plex our per sample with assays currently plexed technology our by twice is our The have the available every for customers is plex XXX competition amount imagers in world the and turnaround customer single choice CosMx as attribute number from and XXXX when grounded assay of offering access already other the using the shoulders real above experience our between opted time or faster the one program, data provided
sample data data we plex which per we're our from and provides AGBT, some than by pushing experiment. platforms. revealed the assay, faster not As expected. RNA were showed XXx X,XXX these provided small To competing an of proof-of-concept clear, human further scaled We anyone be plex that
We at with AGBT X,XXX-plex those two to assay data. presenting use will hand multiple real have research insights. and this discussing worked Then customers to customers of generate their
Our in through is make plan product begin already and development fourth the access year. early to and X,XXX-plex in offering shipping next our it quarter customers available we program technology to to it full
SAHA. Finally, described Chris of the we selected and abstract called opening collaboration used during others Cornell [indiscernible] was AGBT AGBT. Human night Mason Anatomy or highlight new Atlas Weill The an the at Spatial Dr. to SAHA with the the of School of Medicine meeting for exciting
at XX population analyze adults. that a the researchers to to to diverse available Atlas will described, become of make normal crucial Cornell use periodic believe from important therapeutic releases, SAHA around will an tissue reference assay researchers GeoMx from database genetically of transcriptome we Mason enabling organs medicine and approaches. the and may plan healthy world researchers by whole Dr. through The be provided precision tissues different As the which that
CosMx Coming cell clear imaging. the is for out to the of attributes has of us single choice remain AGBT that platform to performance
never confidence the Our spatial penetrate been biology our has in to ability market higher. rapidly
of course is XXXX. to more deliver Our growth second revenue predictable the over objective
In systems instrument to up revenue. CosMx different between a GeoMx resulting in to the year. XXXX, set very demand we is our of struggle mix believe We biology predict be inconsistent and that XXXX spatial
First, recognizing on we're instruments. biology shipping both and spatial revenue
overall the mix. less to revenue be So sensitive will
already Second, instrument are we currently to and revenue we've our expect captured driver that backlog. primary be orders which growth in CosMx
revenue manageable rollout CosMx We'll confidence installs and year. with of balance in remaining XXXX. shipments in us scale a relatively customer and number This and QX, up instrument the at provide pace QX, steady increasing gives in the We growth plan predictability training. then manufacturing of of a of to execute degree the installations a to excellent start experience meter we designed of our over during pace as a high the
knows is demonstrate and our strategic break team towards cash continued This the it. is directive a third Our even. objective everyone progress company on for to prime
cost During about headcount QX, our to XXXX. structure We XXX employees hard to into employees. our XXX about we optimize heading choices made reduced from
we the lowering and break XXXX are the than to guiding substantial loss sustain expecting the exit year, we cash improvement we're our adjusted throughout financial quarter-by-quarter believe with deliver net in XXXX, to are year. We profitable which And and while expenses, an that $XXX resources operating growth. these and hand, to improving in XX% of positioned to For range modestly profile XX%, million our of for equivalents. a more growth our even driving revenue in operations well with
like over to results turn to our review year. financial of provide now to Tom the and call to financial the for I'd our the outlook details